Estimating the morbidity burden of imported chronic schistosomiasis among West African migrants in the Northern Metropolitan Area from Barcelona (Spain): a prospective community-based research.

Schistosomiasis Sub-saharan migrants epidemiology migrants non-endemic countries screening

Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
02 Aug 2024
Historique:
received: 27 03 2024
revised: 22 07 2024
accepted: 24 07 2024
medline: 5 8 2024
pubmed: 5 8 2024
entrez: 4 8 2024
Statut: aheadofprint

Résumé

Past exposure to schistosomiasis is frequent among migrants from endemic countries, and chronic untreated infection may lead to long-term morbidities. We carried out a prospective population-based cross-sectional study among migrants from endemic Sub-Saharan countries living in Barcelona, Spain. Participants had not been previously diagnosed or treated for schistosomiasis. Clinical signs and symptoms were scrutinised through a systematic revision of electronic medical records and an on-site standardized questionnaire, and blood and urine samples were screened for Schistosoma. We recruited 522 eligible participants, 74.3% males, mean age 42.7 years (SD=11.5, range 18-76), Overall, 46.4% were from Senegal and 23.6% from Gambia. They had lived in the European Union for a median of 16 years (IQR 10-21). The prevalence of a Schistosoma-positive serology was 35.8%. S. haematobium eggs were observed in urine samples in 6 (1.2%) participants. The most prevalent symptoms among Schistosoma-positive participants were chronic abdominal pain (68.8%, OR=1.79; 95%CI 1.2-2.6), eosinophilia (44.9%, OR=2.69; 95%CI 1.8-4.0) and specific symptoms associated with urinary schistosomiasis, like self-reported episodes of haematuria (37.2%; OR=2.47; 95%CI 1.6-3.8), dysuria (47.9%, OR=1.84; 95%CI=1.3-2.7) and current renal insufficiency (13.4%; OR=2.35; 95%CI=1.3-4.3). We found a significant prevalence of gender-specific genital signs and symptoms among females (mainly menstrual disorders) and males (erectile dysfunction and pelvic pain). Individuals typically presented with a multitude of interconnected symptoms, most commonly chronic abdominal pain, which is often disregarded. Despite the lack of urine parasite identification, the high incidence of clinical signs and symptoms strongly correlated with a positive schistosomiasis serology suggests the existence of a heavy clinical burden among long-term West African migrants living for years/decades in the study region. More research is urgently required to determine whether these symptoms are the result of long-term sequelae or a persistent active Schistosoma infection.

Sections du résumé

BACKGROUND BACKGROUND
Past exposure to schistosomiasis is frequent among migrants from endemic countries, and chronic untreated infection may lead to long-term morbidities.
METHODS METHODS
We carried out a prospective population-based cross-sectional study among migrants from endemic Sub-Saharan countries living in Barcelona, Spain. Participants had not been previously diagnosed or treated for schistosomiasis. Clinical signs and symptoms were scrutinised through a systematic revision of electronic medical records and an on-site standardized questionnaire, and blood and urine samples were screened for Schistosoma.
FINDINGS RESULTS
We recruited 522 eligible participants, 74.3% males, mean age 42.7 years (SD=11.5, range 18-76), Overall, 46.4% were from Senegal and 23.6% from Gambia. They had lived in the European Union for a median of 16 years (IQR 10-21). The prevalence of a Schistosoma-positive serology was 35.8%. S. haematobium eggs were observed in urine samples in 6 (1.2%) participants. The most prevalent symptoms among Schistosoma-positive participants were chronic abdominal pain (68.8%, OR=1.79; 95%CI 1.2-2.6), eosinophilia (44.9%, OR=2.69; 95%CI 1.8-4.0) and specific symptoms associated with urinary schistosomiasis, like self-reported episodes of haematuria (37.2%; OR=2.47; 95%CI 1.6-3.8), dysuria (47.9%, OR=1.84; 95%CI=1.3-2.7) and current renal insufficiency (13.4%; OR=2.35; 95%CI=1.3-4.3). We found a significant prevalence of gender-specific genital signs and symptoms among females (mainly menstrual disorders) and males (erectile dysfunction and pelvic pain). Individuals typically presented with a multitude of interconnected symptoms, most commonly chronic abdominal pain, which is often disregarded.
CONCLUSIONS CONCLUSIONS
Despite the lack of urine parasite identification, the high incidence of clinical signs and symptoms strongly correlated with a positive schistosomiasis serology suggests the existence of a heavy clinical burden among long-term West African migrants living for years/decades in the study region. More research is urgently required to determine whether these symptoms are the result of long-term sequelae or a persistent active Schistosoma infection.

Identifiants

pubmed: 39098555
pii: S0163-4453(24)00168-3
doi: 10.1016/j.jinf.2024.106234
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106234

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sílvia Roure (S)

International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord,Institut Català de la Salut, Badalona, Spain, ZIP: 08914; Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Electronic address: sroura.mn.ics@gencat.cat.

Xavier Vallès (X)

International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord,Institut Català de la Salut, Badalona, Spain, ZIP: 08914; Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP; Germans Trias i Pujol Research Institute, Badalona, Spain.

Olga Pérez-Quílez (O)

International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord,Institut Català de la Salut, Badalona, Spain, ZIP: 08914.

Israel López-Muñoz (I)

International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord,Institut Català de la Salut, Badalona, Spain, ZIP: 08914.

Lluís Valerio (L)

International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord,Institut Català de la Salut, Badalona, Spain, ZIP: 08914.

Laura Soldevila (L)

International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord,Institut Català de la Salut, Badalona, Spain, ZIP: 08914; Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Anna Chamorro (A)

Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP.

Elena Abad (E)

Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP.

Alaa H A Hegazy (AHA)

Germans Trias i Pujol Research Institute, Badalona, Spain; Microbiology Department, Germans Trias i Pujol University Hospital, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Badalona, Spain; Faculty of Medicine, University of Asyut, El Fateh, Egypt.

Gema Fernández-Rivas (G)

Microbiology Department, Germans Trias i Pujol University Hospital, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Badalona, Spain.

Ester Gorriz (E)

International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord,Institut Català de la Salut, Badalona, Spain, ZIP: 08914.

Dolores Herena (D)

International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord,Institut Català de la Salut, Badalona, Spain, ZIP: 08914.

Elia Fernández-Pedregal (E)

International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord,Institut Català de la Salut, Badalona, Spain, ZIP: 08914; Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Alba San José (AS)

Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP.

Sergio España-Cueto (S)

International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord,Institut Català de la Salut, Badalona, Spain, ZIP: 08914; Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Roger Paredes (R)

Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Jose Miranda-Sánchez (J)

North Metropolitan Primary Care Directorate, Institut Català de la Salut, Sabadell, Spain.

Maria Carme Miralles (MC)

Primary Health Care Unit Canovelles, North Metropolitan Health Region from Barcelona, Institut Català de la Salut, Granollers, Spain.

Carmen Conde (C)

Primary Health Care Unit Canovelles, North Metropolitan Health Region from Barcelona, Institut Català de la Salut, Granollers, Spain.

Juan José Montero (JJ)

Primary Health Care Unit Mataró-3 (Rocafonda-Palau), North Metropolitan Health Region from Barcelona, Institut Català de la Salut, Mataró, Spain.

Maria Amparo Núñez-Andrés (MA)

Department of Civil and Environmental Engineering, Universitat Politècnica de Catalunya-BarcelonaTech, Barcelona, Spain.

Josep M Llibre (JM)

Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Mar Isnard (M)

North Metropolitan Primary Care Directorate, Institut Català de la Salut, Sabadell, Spain.

Josep Maria Bonet (JM)

North Metropolitan Primary Care Directorate, Institut Català de la Salut, Sabadell, Spain.

Oriol Estrada (O)

Directorate for Innovation and Interdisciplinary Cooperation, North Metropolitan Territorial Health Region, Institut Català de la Salut, Badalona, Spain.

Núria Prat (N)

North Metropolitan Primary Care Directorate, Institut Català de la Salut, Sabadell, Spain.

Bonaventura Clotet (B)

Fundació Lluita contra les Infeccions, Badalona, Spain. ZIP; IrsiCaixa-Institut de Recerca de La SIDA, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Direcció Territorial Malalties Infeccioses, North Metropolitan Territorial Health Region, Institut Català de la Salut, Badalona, Spain.

Classifications MeSH